3 results (0,14846 seconds)

Show all filters

Brand

Merchant

Price (EUR)

Reset filter

Products
From
Shops

The Shroud of Christ Evidence of a 2 000 Year Antiquity

The Shroud of Christ Evidence of a 2 000 Year Antiquity

The Shroud of Turin has been the focus of extensive study by historians and researchers since the beginning of the twentieth century. It is possibly the world’s most studied historical artifact generating a regular flow of new research publications. There is however one scientific test that overshadows all other research: the 1988 radiocarbon dating. This test dated the cloth to the period 1260–1390AD and was given such extensive publicity that most people today no longer accept the Shroud to be a true relic. Sadly very few people are aware that this test has been widely criticized for falling short of acceptable scientific standards. Similarly most people remain unaware of the wealth of compelling evidence that contradicts the conclusions of that test and supports claims of the Shroud’s authenticity. This book reveals extracts from secret discussions on dating evidence from the Shroud Science Group a private international forum of Shroud researchers and provides a detailed account of the dating evidence revealed by over a hundred years of research. It outlines reasons why the 1988 radiocarbon dating test continues to attract criticism from respected scientists and also describes a series of innovative flax dating techniques which have recently been used measure the age of Shroud material producing results that contradict the radiocarbon date. | The Shroud of Christ Evidence of a 2 000 Year Antiquity

GBP 61.99
1

Pharmaceutical Biocatalysis Important Enzymes Novel Targets and Therapies

Pharmaceutical Biocatalysis Important Enzymes Novel Targets and Therapies

This volume of Pharmaceutical Biocatalysis starts with a discussion on the importance of biocatalytic synthesis approaches for a sustainable and environmentally friendly production of pharmaceuticals and active pharmaceutical ingredients. Among the enzymes discussed in detail with respect to their pharmaceutical relevance are cyclic nucleotide phosphodiesterases playing an important role in modulating signal transduction in various cell types; human DOPA decarboxylase related to Parkinson's disease and aromatic amino acid decarboxylase deficiency; and phospholipase D enzymes as drug targets. Isocitrate dehydrogenase 1 and 2 mutations are novel therapeutic targets in acute myeloid leukemia. An additional chapter is devoted to the use of enzymes for prodrug activation in cancer therapy. The other topics include small-molecule inhibitors targeting receptor tyrosine kinases in cancer β-Lactams and related compounds as antibacterials non-vitamin K oral anticoagulants for the treatment of thromboembolic diseases and the molecular mechanisms for statin pleiotropy and its clinical relevance in cardiovascular diseases. The last chapter is a review of lysosomal storage disorders with an overview of approved drugs for treating these disorders by enzyme replacement therapy. | Pharmaceutical Biocatalysis Important Enzymes Novel Targets and Therapies

GBP 193.00
1

Gallium Nitride Power Devices

Gallium Nitride Power Devices

GaN is considered the most promising material candidate in next-generation power device applications owing to its unique material properties for example bandgap high breakdown field and high electron mobility. Therefore GaN power device technologies are listed as the top priority to be developed in many countries including the United States the European Union Japan and China. This book presents a comprehensive overview of GaN power device technologies for example material growth property analysis device structure design fabrication process reliability failure analysis and packaging. It provides useful information to both students and researchers in academic and related industries working on GaN power devices. GaN wafer growth technology is from Enkris Semiconductor currently one of the leading players in commercial GaN wafers. Chapters 3 and 7 on the GaN transistor fabrication process and GaN vertical power devices are edited by Dr. Zhihong Liu who has been working on GaN devices for more than ten years. Chapters 2 and 5 on the characteristics of polarization effects and the original demonstration of AlGaN/GaN heterojunction field-effect transistors are written by researchers from Southwest Jiaotong University. Chapters 6 8 and 9 on surface passivation reliability and package technologies are edited by a group of researchers from the Southern University of Science and Technology of China. | Gallium Nitride Power Devices

GBP 139.00
1